HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Zeroes In On “Natural” Personal-Care Claims, Skin Supplements In 2009

This article was originally published in The Rose Sheet

Executive Summary

The National Advertising Division is focusing more on "natural" personal-care advertising in 2009 and urging companies with complaints about a competitor's natural claims to take advantage of its services by filing challenges

You may also be interested in...



NAD Continues To Wear Consumer’s Shoes When Assessing ‘Natural’ Claims

Much has changed since the National Advertising Division reviewed Tom’s Of Maine’s Natural Mouthwash claims in 1998, referring at the time to the “small segment of consumers that have heightened concerns and expectations” regarding natural products. Despite the market’s explosion, “natural” remains undefined by regulators, and NAD continues to assess the truthfulness of claims on a case-by-case basis.

BeautyScoop Creator Touts Advantages Over Other Nutraceuticals, Topicals

Co-creator of nutraceutical BeautyScoop maintains that her product offers advantages over both competing skin-care ingestibles and topical peptide-based formulas for promoting skin health

BeautyScoop Creator Touts Advantages Over Other Nutraceuticals, Topicals

Co-creator of nutraceutical BeautyScoop maintains that her product offers advantages over both competing skin-care ingestibles and topical peptide-based formulas for promoting skin health

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel